The use of remanufactured single-use devices (SUDs), including cardiac electrophysiology catheters, has become established in the USA and other health care systems but without much published scientific evaluation on the relative safety or efficacy of these devices. In the United Kingdom (UK), the use of remanufactured SUDs has not been routine. We performed a structured evaluation of the safety and efficacy of a remanufactured circular mapping catheter (Stryker® remanufactured Lasso NAV 2515) during its introduction in our centre.
We prospectively evaluated the performance of a remanufactured circular mapping catheter in 100 consecutive patients undergoing an AF ablation. Operator feedback was obtained, assessing the device appearance, ease of use and function. As an indirect measurement of efficacy, acute procedure metrics were compared to those in 100 propensity-matched cases performed by the same operators using a new device. Cost savings were calculated.
No complication occurred in association with the remanufactured device. There was one reported failure of device malfunction—the flexion-extension mechanism of a remanufactured catheter and none in the matched-control group. There was satisfactory communication with the electro-anatomic mapping system. Ease of use of the remanufactured catheter was reported to be similar to a newly manufactured device. Procedural duration was similar with remanufactured devices and matched controls. With 100 cases using the remanufactured device, cost savings amounted to £30,444.
The use of remanufactured circular mapping catheters is safe, efficient and reliable. Widespread use of remanufactured SUDs offers the possibility of significant economic benefit.
United States Government Accountability Office. Reprocessed Single-Use Medical Devices: FDA Oversight Has Increased and Available Information Does Not Indicate That Use Presents an Elevated Health Risk. http://www.gao.gov/new.items/d08147.pdf. Accessed 19 Jan 2018.
Johnsen SP, Dalby LW, Täckström T, Olsen J, Fraschke A. Cost of illness of atrial fibrillation: a nationwide study of societal impact. BMC Health Serv Res. 2017;17:714. CrossRef
Colak T, Ersoz G, Akca T, Kanik A, Efficacy AS. Safety of reuse of disposable laparoscopic instruments in laparoscopic cholecystectomy: a prospective randomised study. Surg Endosc. 2004;18(5):727–31. CrossRef
DaSilva M, Ribeiro A, Pinto T. Safety evaluation of single-use devices after submission to simulated reutilization cycles. J AOAC Int. 2005;88(3):823–9.
Fedel M, Tessarolo F, Ferrari P, Lösche C, Ghassemieh N, Guarrera GM, et al. Functional properties and performance of new and reprocessed coronary angioplasty balloon catheters. J Biomed Mater Res. 2006;78(2):364–72. CrossRef
Lipp M, Jaehnichen G, Golecki N, Fecht G, Reichl R, Microbiological HP. Microstructure and material science Examinations of Reprocessed Combitubes after Multiple Reuse. Anesth Analg. 2000;9:1693–7.
Roth K, Heeg P, Reichl R. Specific hygiene issues relating to reprocessing and reuse of single-use devices for laparoscopic surgery. Surg Endosc. 2002;16(7):1091–7. CrossRef
Ironside JW. Variant Creutzfeldt-Jakob disease: an update. Folia Neuropathol. 2012;50(1):50–6. PubMed
Hamaguchi T, Noguchi-Shinohara M, Nozaki I, Kakamura Y, Sato T, Kitamoto T, et al. The risk of iatrogenic Cruetzfeldt-Jakob disease through medical and surgical procedures. Neuropathology. 2009;29(5):625–31. CrossRef
Antloga K, Meszaros J, Malchesky PS, McDonnell GE. Prion disease and medical devices. ASAIO J. 2000;46(6):S69–72. CrossRef
Henderson DK. Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev. 2003;16(3):546–68. CrossRef
Druce JD, Russell JS, Birch CJ, Vickery K, Harper RW, Smolich JJ. Cleaning and sterilisation protocol for reused cardiac electrophysiology catheters inactivates hepatitis and coxsackie viruses. Infect Control Hosp Epidemiol. 2005;26(8):720–5. CrossRef
Department of Health. NHS assessment of remanufactured single-use devices. London: the stationery. Office. 2016:1–24.
Draft MHRA Guidance on Remanufacturing. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/447046/Singleuse_medical_devices-UK_guidance_on_re-manufacturing-draft.pdf. Accessed 19 Jan 2018.
Council Directive 93/42/EEC concerning Medical Devices OJ L169 OF 12 July 1993 last amended by Directive 2007/47/EC.
Council Directive 90/385/EEC concerning Active Implantable Medical Devices OJ L189 of 20 July 1990 last amended by Directive 2007/47/EC.
Stryker® Internal Report, Stryker®’s Sustainability Solutions division; (Document Code: MKT10144REVBUSAEN); 2018; unpublished.
The European Commission Guidelines on a Medical Devices Vigilance System MEDDEV 2.12-1 Rev 8, January 2013.
National Institute of Clinical Excellence (NICE) IPG121. Radiofrequency ablation for atrial fibrillation in association with other cardiac Surgery. May 2005. https://www.nice.org.uk/guidance/ipg121. Accessed 19 Jan 2018.
NICE IPG 168. Percutaneous Radiofrequency Ablation for Atrial Fibrillation. April 2006. https://www.nice.org.uk/guidance/ipg168. Accessed 19 Jan 2018.
Brann H, Capone A. A tale of two different SUD reprocessing programs: how two similar healthcare systems can achieve very different savings results in the EP Lab. EP Lab Digest. 2015:36–37.
- Remanufactured circular mapping catheters: safety, effectiveness and cost
Lisa WM Leung
Mark M. Gallagher
- Springer US
Journal of Interventional Cardiac Electrophysiology
An International Journal of Cardiac Arrhythmias and Rhythm Management
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
Neu im Fachgebiet Kardiologie
Mail Icon II